LNSR Q2 2023 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12M+49.4% YoY

Gross Profit

$7M56.3% margin

Operating Income

-$3M-23.9% margin

Net Income

-$9M-72.9% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

+45.6%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$71M

Total Liabilities

$39M

Stockholders' Equity

$33M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+49.4%
Gross Profit	$7M	$5M	+38.2%
Operating Income	-$3M	-$7M	+57.8%
Net Income	-$9M	-$7M	-29.5%

Revenue Segments

Product

$9M91%

Service

$944,0009%

Geographic Segments

UNITED STATES

$7M69%

Europe

$2M19%

Asia Excluding South Korea

$1M11%

Other Geographical Region

$89,0001%

KOREA, REPUBLIC OF

$16,0000%